| Lee Brock Wren, OD | |
|
715 W Judicial St, Blackfoot, ID 83221-2036 | |
| (208) 785-2210 | |
| (208) 785-2216 |
| Full Name | Lee Brock Wren |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 17 Years |
| Location | 715 W Judicial St, Blackfoot, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215120696 | NPI | - | NPPES |
| 1215120696 | Medicaid | ID | |
| 66612099900001 | Other | UT | BLUE CROSS/BLUE SHIELD |
| 999000797009 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 66612099934 (Utah) | Secondary |
| 152W00000X | Optometrist | ODP-100148 (Idaho) | Primary |
| Provider Name | Bingham Family Vision Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336624030 PECOS PAC ID: 7315287505 Enrollment ID: O20190326001826 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that it has entered into a collaboration and license agreement with Bicycle Therapeutics to develop and commercialize novel drugs inhibiting a specific target for the treatment of ophthalmic diseases, such as diabetic macular edema.
Ablative Solutions, Inc., a venture-backed, privately-held clinical stage company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it was the recipient of a "Top Cardiovascular Innovation Award" from Cardiovascular Research Technologies for the Peregrine System.
Researchers at LSTM, working with colleagues at the Centres for Disease Control and Prevention USA, the Kenya Medical Research Institute, and from the London School of Hygiene and Tropical Medicine, have completed a study to assess the acceptability among pregnant women and health providers in Kenya of a new drug as an alternative to the standard drug used to prevent malaria in pregnancy.
Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine.
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the University, today announced that Professor L.D. Shvartsman and Professor B. Laikhtman, from the Racah Institute of Physics at the Hebrew University of Jerusalem, have invented a novel design of TeraHertz-ray, or T-ray, lasers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lee Brock Wren, OD 715 W Judicial St, Blackfoot, ID 83221-2036 Ph: (208) 785-2210 | Lee Brock Wren, OD 715 W Judicial St, Blackfoot, ID 83221-2036 Ph: (208) 785-2210 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that it has entered into a collaboration and license agreement with Bicycle Therapeutics to develop and commercialize novel drugs inhibiting a specific target for the treatment of ophthalmic diseases, such as diabetic macular edema.
Ablative Solutions, Inc., a venture-backed, privately-held clinical stage company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it was the recipient of a "Top Cardiovascular Innovation Award" from Cardiovascular Research Technologies for the Peregrine System.
Researchers at LSTM, working with colleagues at the Centres for Disease Control and Prevention USA, the Kenya Medical Research Institute, and from the London School of Hygiene and Tropical Medicine, have completed a study to assess the acceptability among pregnant women and health providers in Kenya of a new drug as an alternative to the standard drug used to prevent malaria in pregnancy.
Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine.
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the University, today announced that Professor L.D. Shvartsman and Professor B. Laikhtman, from the Racah Institute of Physics at the Hebrew University of Jerusalem, have invented a novel design of TeraHertz-ray, or T-ray, lasers.
› Verified 2 days ago
Mr. Cody E Jones, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 34 Se Main St, Ste 101, Blackfoot, ID 83221 Phone: 208-785-7274 Fax: 208-785-7337 | |
Dr. Cameron Keith Housley, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 720 N Meridian St Ste A, Blackfoot, ID 83221 Phone: 208-785-7274 | |
Bingham Family Vision, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 715 W Judicial St, Blackfoot, ID 83221 Phone: 208-785-2210 Fax: 208-785-2216 | |
Dennis N Marshall, O.D., P.A. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1495 Parkway Dr Ste A, Blackfoot, ID 83221 Phone: 208-785-3063 Fax: 208-782-1392 | |
Complete Family Eye Care, Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 34 Se Main St Ste 101, Blackfoot, ID 83221 Phone: 208-785-7274 | |
Dennis N. Marshall, O.d., P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 1495 Parkway Dr Ste A, Blackfoot, ID 83221 Phone: 208-785-3063 Fax: 208-782-1392 |